J&J Wins Patent Dispute Over Birth Control Drug

Law360, New York (September 11, 2012, 8:42 PM EDT) -- A New Jersey federal judge Tuesday declared valid the patent behind Johnson & Johnson's Ortho Tri-Cyclen Lo birth control drug, blocking a Lupin Pharmaceuticals Inc. effort to market a generic competitor.

U.S. District Judge Stanley R. Chesler rejected Lupin's claims that a patent owned by J&J subsidiary Janssen Pharmaceuticals for the oral contraceptive was invalid as either obvious or anticipated.

The judge struck down a slew of arguments for why the formula wasn't patentable, among them Lupin's claim that a skilled artisan would have found it...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.